1. A T‐cell diagnostic test for cystic echinococcosis based on Antigen B peptides. (24th November 2017) Authors: Petrone, L.; Vanini, V.; Amicosante, M.; Corpolongo, A.; Gomez Morales, M. A.; Ludovisi, A.; Ippolito, G.; Pozio, E.; Teggi, A.; Goletti, D. Journal: Parasite immunology Issue: Volume 39:Number 12(2017:Dec.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis. (September 2017) Authors: Petruccioli, E.; Vanini, V.; Chiacchio, T.; Cuzzi, G.; Cirillo, D.M.; Palmieri, F.; Ippolito, G.; Goletti, D. Journal: Tuberculosis Issue: Volume 106(2017) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study. (21st January 2016) Authors: Kovari, Helen; Sabin, Caroline A.; Ledergerber, Bruno; Ryom, Lene; Reiss, Peter; Law, Matthew; Pradier, Christian; Dabis, Francois; d'Arminio Monforte, Antonella; Smith, Colette; de Wit, Stephane; Kirk, Ole; Lundgren, Jens D.; Weber, Rainer; Powderly, B.; Shortman, N.; Moecklinghoff, C.; Reilly, ... Journal: Open forum infectious diseases Issue: Volume 3:Number 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. COVID-19, SARS and MERS: are they closely related?. (June 2020) Authors: Petrosillo, N.; Viceconte, G.; Ergonul, O.; Ippolito, G.; Petersen, E. Journal: Clinical microbiology and infection Issue: Volume 26:Number 6(2020) Page Start: 729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. COVID‐19 and renin‐angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy?. (8th June 2020) Authors: Aleksova, A.; Ferro, F.; Gagno, G.; Cappelletto, C.; Santon, D.; Rossi, M.; Ippolito, G.; Zumla, A.; Beltrami, A. P.; Sinagra, G. Journal: Journal of internal medicine Issue: Volume 288:Number 4(2020) Page Start: 410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Detection of viral RNA in tissues following plasma clearance from an Ebola virus infected patient. (December 2016) Authors: Biava, M.; Caglioti, C.; Bordi, L.; Castilletti, C.; Colavita, F.; Quartu, S.; Nicastri, E.; Lauria, F.N.; Petrosillo, N.; Lanini, S.; Hoenen, T.; Kobinger, G.; Zumla, A.; Di Caro, A.; Ippolito, G.; Capobianchi, M.R.; Lalle, E. Journal: International journal of infectious diseases Issue: Volume 53(2016:Dec.)Supplement Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EBOLA Ag K-SeT rapid test: field evaluation in Sierra Leone. (June 2018) Authors: Colavita, F.; Biava, M.; Mertens, P.; Gilleman, Q.; Borlon, C.; Delli Guanti, M.; Petrocelli, A.; Cataldi, G.; Kamara, A.T.; Kamara, S.A.; Konneh, K.; Vincenti, D.; Castilletti, C.; Abdurahman, S.; Mirazimi, A.; Capobianchi, M.R.; Ippolito, G.; Miccio, R.; Di Caro, A. Journal: Clinical microbiology and infection Issue: Volume 24:Number 6(2018) Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals. (October 2016) Authors: Ippolito, G.; Antonelli, G. Journal: Clinical microbiology and infection Issue: Volume 22:Number 10(2016) Page Start: 824 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52). (June 2018) Authors: Mikulska, M.; Lanini, S.; Gudiol, C.; Drgona, L.; Ippolito, G.; Fernández-Ruiz, M.; Salzberger, B. Journal: Clinical microbiology and infection Issue: Volume 24: Supplement 2(2018) Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4). (June 2018) Authors: Drgona, L.; Gudiol, C.; Lanini, S.; Salzberger, B.; Ippolito, G.; Mikulska, M. Journal: Clinical microbiology and infection Issue: Volume 24: Supplement 2(2018) Page Start: S83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗